ORKA
Oruka Therapeutics·NASDAQ
--
--(--)
--
--(--)
8.06 / 10
Outperform
Analyst consensus is strongly positive: 6 of 6 analysts rate Buy or Strong Buy, with historic win rates up to 100%. Fund‑flow score is 7.75, showing overall inflow, though Small and Medium segments show slight outflows.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
50%
Buy
50%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-13
InstitutionStifel
Times predicted1
Historical Win Rate100.0%
Is money flowing into or out of ORKA?
- ORKA holds a Bullish analyst rating, with 50% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 8.06/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
